Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes
Permalink
Citation
Harjutsalo , V , Maric-Bilkan , C , Forsblom , C , Groop , P-H & FinnDiane Study Grp 2016 , ' Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes ' , Diabetologia , vol. 59 , no. 3 , pp. 472-480 . https://doi.org/10.1007/s00125-015-3816-0
| Title: | Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes |
| Author: | Harjutsalo, Valma; Maric-Bilkan, Christine; Forsblom, Carol; Groop, Per-Henrik; FinnDiane Study Grp |
| Other contributor: |
University of Helsinki, Department of Medical and Clinical Genetics
University of Helsinki, Clinicum University of Helsinki, Clinicum |
| Date: | 2016-03 |
| Language: | eng |
| Number of pages: | 9 |
| Belongs to series: | Diabetologia |
| ISSN: | 0012-186X |
| DOI: | https://doi.org/10.1007/s00125-015-3816-0 |
| URI: | http://hdl.handle.net/10138/224046 |
| Abstract: | Aims/hypothesis The aim of this study was to evaluate the relationship among age at onset of diabetes, age at onset of menarche and risk of diabetic nephropathy and laser-treated retinopathy in type 1 diabetes. Methods Data related to age at menarche were collected through questionnaires and were available for 1,304 women who participated in the Finnish Diabetic Nephropathy Study (FinnDiane). A possible association between age at menarche and diabetic nephropathy and retinopathy was investigated. Results There was an inverse relationship between the age at onset of diabetes and age at menarche: the younger the age at onset of diabetes, the higher the age at menarche (p <0.0001). A non-linear relationship between the age of menarche and risk of diabetic microvascular complications was found in patients with diabetes onset before menarche, but there was no such association in patients with diabetes onset after menarche. Women with delayed menarche (> mean age+ 2 years) had a 2.30 (95% CI 1.27, 4.17; p <0.006) times higher risk of nephropathy compared with the women who underwent menarche at the mean age +/- 2 years. Delayed menarche also increased the risk of retinopathy (OR 2.34 [95% CI 1.36, 4.01]). After excluding patients with nephropathy, the OR for retinopathy was 2.11 (95% CI 1.15, 3.90). Earlier menarche (<mean age-2 years) did not have any effect on this risk. Conclusions/interpretation Delayed menarche was associated with an increased risk of diabetic nephropathy and retinopathy, whereas early menarche was not. Delayed menarche may be used as a new tool to identify women at risk of diabetic microvascular complications. |
| Subject: |
Age at menarche
Age at onset of diabetes Delayed menarche Diabetic nephropathy Diabetic retinopathy Puberty Type 1 diabetes STAGE RENAL-DISEASE METABOLIC-CONTROL NATURAL-HISTORY NEPHROPATHY MELLITUS PUBERTY WOMEN MICROALBUMINURIA ADOLESCENTS ONSET 3121 General medicine, internal medicine and other clinical medicine |
| Rights: |
Files in this item
Total number of downloads: Loading...
| Files | Size | Format | View |
|---|---|---|---|
| art_3A10.1007_2Fs00125_015_3816_0.pdf | 421.1Kb |
View/ |
This item appears in the following Collection(s)
-
Articles from TUHAT CRIS [40322]
Related items
Showing items related by title, author, creator and subject.
-
(2021)Aims/hypothesis Diabetes and diabetes complications are a cause of substantial morbidity, resulting in early exits from the labour force and lost productivity. The aim of this study was to examine differences in early exits between people with type 1 and 2 diabetes and to assess the role of chronic diabetes complications on early exit. We also estimated the economic burden of lost productivity due to early exits. Methods People of working age (age 17-64) with diabetes in 1998-2011 in Finland were detected using national registers (N-type 1 = 45,756, N-type 2 = 299,931). For the open cohort, data on pensions and deaths, healthcare usage, medications and basic demographics were collected from the registers. The outcome of the study was early exit from the labour force defined as pension other than old age pension beginning before age 65, or death before age 65. We analysed the early exit outcome and its risk factors using the Kaplan-Meier method and extended Cox regression models. We fitted linear regression models to investigate the risk factors of lost working years and productivity costs among people with early exit. Results The difference in median age at early exit from the labour force between type 1 (54.0) and type 2 (58.3) diabetes groups was 4.3 years. The risk of early exit among people with type 1 diabetes increased faster after age 40 compared with people with type 2 diabetes. Each of the diabetes complications was associated with an increase in the hazard of early exit regardless of diabetes type compared with people without the complication, with eye-related complications as an exception. Diabetes complications partly but not completely explained the difference between diabetes types. The mean lost working years was 6.0 years greater in the type 1 diabetes group than in the type 2 diabetes group among people with early exit. Mean productivity costs of people with type 1 diabetes and early exit were found to be 1.4-fold greater compared with people with type 2 diabetes. The total productivity costs of incidences of early exits in the type 2 diabetes group were notably higher compared with the type 1 group during the time period (euro14,400 million, euro2800 million). Conclusions/interpretation We found a marked difference in the patterns of risk of early exit between people with type 1 and type 2 diabetes. The difference was largest close to statutory retirement age. On average, exits in the type 1 diabetes group occurred at an earlier age and resulted in higher mean lost working years and mean productivity costs. The potential of prevention, timely diagnosis and management of diabetes is substantial in terms of avoiding reductions in individual well-being and productivity.
-
(2019)Objective: To evaluate the independent or combined effects of gestational diabetes (GDM) and pre-pregnancy and postpartum BMI on the odds of postpartum diabetes and hyperglycemia. Methods: The study samples included 1263 women with prior GDM and 705 women without GDM. Postpartum 1-7 years diabetes was diagnosed by the standard oral glucose tolerance test. Results: The multivariable-adjusted odds ratios among women with prior GDM, compared with those without it, were 7.52 for diabetes and 2.27 for hyperglycemia. The multivariable-adjusted odds ratios at different postpartum BMI levels (= 28 kg/m(2)) were 1.00, 2.80, and 8.08 for diabetes (P-trend <0.001), and 1.00, 2.10, and 4.42 for hyperglycemia (P-trend <0.001), respectively. Women with high body fat (>= 31.9%) or abdominal obesity (>= 85 cm) had a 2.7-6.9-fold higher odds ratio for diabetes or hyperglycemia. Women with both obesity and prior GDM had the highest risk of diabetes or hyperglycemia compared with non-obese women without GDM. Non-obese women with prior GDM had the same risk of diabetes and hyperglycemia as non-GDM women with obesity. When using Cox regression models, the results were very close to those using logistic regression models. Conclusions: Maternal prior GDM and pre-pregnancy or postpartum obesity contribute equally to postpartum diabetes and hyperglycemia risk. (C) 2019 Elsevier B.V. All rights reserved.